novo nordisk glp 1 drugs promotes new GLP-1 receptor agonist to fight diabetes, obesity < Pharma < Article Article » PBD
Description
Stefan Macher: declares no conflict of interest relevant to this study
doi: 10.1016/j.psc.2011.08.006
While uncommon, pancreatitis is serious and requires immediate medical attention
Before diving into GLP-1 versus GIP specifically, understanding incretin hormones as a category provides helpful context
doi: 10.2174/1567201816666191010145029 229 DrabSR
But the short-term fallout isnt looking good for either former partner
